Latent Tuberculosis Infection (LTBI) Testing Market Report

Global and Region Latent Tuberculosis Infection (LTBI) Testing Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：146
  • REPORT CODE：GMM891401
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Latent Tuberculosis Infection (LTBI) Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Latent Tuberculosis Infection (LTBI) Testingmarket, defines the market attractiveness level of Latent Tuberculosis Infection (LTBI) Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Latent Tuberculosis Infection (LTBI) Testing industry, describes the types of Latent Tuberculosis Infection (LTBI) Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Latent Tuberculosis Infection (LTBI) Testing market and the development prospects and opportunities of Latent Tuberculosis Infection (LTBI) Testing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Latent Tuberculosis Infection (LTBI) Testing market in Chapter 13.

    By Player:

    • Danaher

    • Bio-Rad Laboratories

    • Abbott Laboratories

    • Eppendorf

    • BioMerieux

    • Roche

    • Qiagen

    • Agilent Technologies

    • Thermo Fisher Scientific

    • Becton Dickinson

    By Type:

    • Tuberculin Skin Test (TST)

    • Interferon Gamma Released Assay (IGRA)

    • Others

    By End-User:

    • Household Contacts with Pulmonary TB

    • PLHIV

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Latent Tuberculosis Infection (LTBI) Testing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Latent Tuberculosis Infection (LTBI) Testing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Latent Tuberculosis Infection (LTBI) Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Latent Tuberculosis Infection (LTBI) Testing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Latent Tuberculosis Infection (LTBI) Testing Market Analysis and Outlook to 2022

    • 7.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    • 7.2 United States Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    • 7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    • 7.4 China Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    • 7.5 Japan Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    • 7.6 India Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    • 7.7 South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption (2017-2022)

    8 Region and Country-wise Latent Tuberculosis Infection (LTBI) Testing Market Analysis and Outlook to 2028

    • 8.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    • 8.2 United States Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    • 8.3 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    • 8.4 China Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    • 8.5 Japan Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    • 8.6 India Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    • 8.7 South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast (2022-2028)

    9 Global Latent Tuberculosis Infection (LTBI) Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tuberculin Skin Test (TST) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Interferon Gamma Released Assay (IGRA) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Household Contacts with Pulmonary TB Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global PLHIV Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Latent Tuberculosis Infection (LTBI) Testing Market Outlook by Types and Applications to 2028

    • 10.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Tuberculin Skin Test (TST) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Interferon Gamma Released Assay (IGRA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Household Contacts with Pulmonary TB Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global PLHIV Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Latent Tuberculosis Infection (LTBI) Testing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Latent Tuberculosis Infection (LTBI) Testing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Latent Tuberculosis Infection (LTBI) Testing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Latent Tuberculosis Infection (LTBI) Testing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Latent Tuberculosis Infection (LTBI) Testing Market Competitive Analysis

    • 14.1 Danaher

      • 14.1.1 Danaher Company Details

      • 14.1.2 Danaher Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Danaher Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.2 Bio-Rad Laboratories

      • 14.2.1 Bio-Rad Laboratories Company Details

      • 14.2.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.3 Abbott Laboratories

      • 14.3.1 Abbott Laboratories Company Details

      • 14.3.2 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.4 Eppendorf

      • 14.4.1 Eppendorf Company Details

      • 14.4.2 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.5 BioMerieux

      • 14.5.1 BioMerieux Company Details

      • 14.5.2 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.6 Roche

      • 14.6.1 Roche Company Details

      • 14.6.2 Roche Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Roche Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.7 Qiagen

      • 14.7.1 Qiagen Company Details

      • 14.7.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.8 Agilent Technologies

      • 14.8.1 Agilent Technologies Company Details

      • 14.8.2 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.9 Thermo Fisher Scientific

      • 14.9.1 Thermo Fisher Scientific Company Details

      • 14.9.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • 14.10 Becton Dickinson

      • 14.10.1 Becton Dickinson Company Details

      • 14.10.2 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Latent Tuberculosis Infection (LTBI) Testing

    • Figure Latent Tuberculosis Infection (LTBI) Testing Picture

    • Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Latent Tuberculosis Infection (LTBI) Testing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Latent Tuberculosis Infection (LTBI) Testing Consumption by Country (2017-2022)

    • Figure United States Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate (2017-2022)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate (2017-2022)

    • Figure India Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tuberculin Skin Test (TST) Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Gamma Released Assay (IGRA) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Household Contacts with Pulmonary TB Consumption and Growth Rate (2017-2022)

    • Figure Global PLHIV Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Tuberculin Skin Test (TST) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Gamma Released Assay (IGRA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Household Contacts with Pulmonary TB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PLHIV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Latent Tuberculosis Infection (LTBI) Testing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Latent Tuberculosis Infection (LTBI) Testing Export by Region (Top 5 Countries) (2017-2028)

    • Table Danaher (Foundation Year, Company Profile and etc.)

    • Table Danaher Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Bio-Rad Laboratories (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Eppendorf (Foundation Year, Company Profile and etc.)

    • Table Eppendorf Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eppendorf Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table BioMerieux (Foundation Year, Company Profile and etc.)

    • Table BioMerieux Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Qiagen (Foundation Year, Company Profile and etc.)

    • Table Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Agilent Technologies (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Service

    • Table Becton Dickinson (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US